The Brazilian MMA Athletic Commission have announced that UFC lightweight fighter Piotr Hallmann tested positive for the anabolic steroid Drostanolone after his bout at UFC Fight night 51 last month.
Hallmann lost his fight with Gleison Tibau by split decision on the night, but had earned a ‘Fight Of The Night’ bonus along the way.
However, that $50,000 bonus has now been rescinded as a result of his steroid use and he’s also been handed a nine month suspension from the sport and will have to pass a drug test upon his return.
The 27 year-old Polish fighter has compiled a 2-2 record so far in the UFC, defeating Francisco Trinaldo and Yves Edwards in the Octagon, while also picking up a loss to Al Iaquinta in addition to his most recent defeat against Tibau.
UFC CEO Lorenzo Fertitta recently announced that the company are planning to step up their drug testing procedures even further in order to clean up the sport.
They’ve already raised their game by ensuring that every single fighter on each card is tested on the night of their fight, but according to Fertitta in an interview on the UFC Tonight show last week the next step is, “a complete project where we will random test all 500 of our athletes multiple times per year.”